Press

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits.This is where we post all our press releases. If you are a journalist interested in learning more about the biotechnology sector, contact Agathe Cortes, our Head of Communication: acortes@asebio.com

Search engine
Biotecnología_terapias_avanzadas_AseBio
AseBio
The commercial corporation of advanced therapies, an opportunity to leverage Spanish development and production capabilities in a global and highly competitive market
Healthcare · Advanced therapies
  • With the creation of this commercial corporation, it is expected to "bring two advanced therapies to authorization and commercialization in 2027 manufactured in Spain."
  • The Spanish biotech industry is present throughout the value chain of advanced therapy development and manufacturing, with 47 entities working in this field.
  • Over 30 biotechnology companies have capabilities for the complete development of advanced therapies in Spain: from the initial R&D phases to manufacturing processes, transfer, and distribution.
Diana_Morant_ministra_Ciencia_Innovación_Universidades_AseBio
AseBio
AseBio, AESEMI, Cotec Foundation, and Secpho celebrate the launch by the Ministry of Science, Innovation, and Universities of the Deep Tech Strategy
Corporate
  • The future Deep Tech Strategy takes up the challenge of the proposal for the creation of a High Commissioner for Deep Strategic Technologies made jointly by the four entities.
  • We consider that the strategy captures the cross-cutting nature that characterizes 'deep tech' through the involvement of various ministries, and an approach that covers the entire value chain.
  • We make our experience and knowledge available to the ministry to work on the development of the Deep Tech Strategy, and for it to meet the needs of entities operating in the field of 'deep tech'.
Día_Internacional_Mujer_AseBio
AseBio
The biotechnology sector, spearheading women's leadership in Spain
Services · Talento
  • AseBio organizes the event "Women in Biotech for Better Science and Innovation," highlighting the significant role of women in the biotechnology industry.
  • In addition, the names of professional women and student participants in the second edition of the "A Day with a #WomanBiotech" program have been unveiled.
  • Women's representation in the Spanish biotech sector remains at 53%, and they make up 28.4% of the management teams in biotechnology companies. Among these, 58% of the personnel dedicated to R&D activities are women.
Enfermedades_Raras_Biotecnología_AseBio
AseBio
Biotechnology emerges as a key player in the fight against rare diseases
Healthcare · Rare diseases
  • In Spain, around three million people live with rare diseases or are in search of a diagnosis.
  • Only 20% of the over 6,300 rare diseases identified in Europe are currently under investigation.
  • In recent decades, biotechnology has transformed the approach to rare diseases through the discovery of new drugs, the development of advanced therapies, or biomarkers.
Premios_Periodismo
AseBio
The 'AseBio Journalism Awards', organized within the framework of BIOSPAIN 2023, recognize the work of journalists Belén Diego and Miguel Sanmartín
BioSpain · Communication
  • Belén Diego is a contributor to Diariofarma and correspondent for APM Health Europe in Spain and Portugal, while Miguel Sanmartín is the founder of Capital Radio and host of the program 'Biotecnología Capital'.
  • The winning pieces have been chosen as the two best coverages of BIOSPAIN 2023 by the jury among all the received nominations.
  • Following the award ceremony, a debate with professionals in scientific communication has been held, where the main challenges and opportunities were analyzed.
Biomasa_biotecnología_AseBio
AseBio
Biotechnology, key in reducing dependence on fossil fuels and developing alternative energy sources
Climate change · Bioeconomy · Circular economy
  • Coal, oil, and gas account for over 75% of total global greenhouse gas emissions and nearly 90% of all carbon dioxide emissions.
  • Biotechnology is crucial in reducing the use of fossil fuels and in the development of alternative energy sources that are clean, accessible, affordable, sustainable, and reliable.
  • Bioenergy, biofuels, biological treatment of waste and wastewater, reduction of atmospheric emissions, or improvement of energy efficiency are just some examples of the responses offered by the biotechnology sector to this challenge.
NGT_biotecnología_AseBio
AseBio
AseBio positively values the regulatory advancements regarding NGTs following the European Parliament's vote
Agrifood · Food & feed · Agriculture
  • Europe aims to progress towards a more sustainable and resilient food system through the development of improved plant varieties.
  • Following the vote on February 7th, the European Parliament will be able to initiate negotiations with the Member States for the creation of the definitive law.
  • We hope that the approval of this law will occur before the European elections taking place between June 6th and 9th, 2024.
Nuevas_Técnicas_Edición_Genómica_AseBio
AseBio
AseBio, AEPLA, ANOVE, and the ANTAMA Foundation urge European legislators to vote in favor of the proposed adequate regulation on NGTs
Agrifood · Food & feed · Agriculture
  • The Parliament is expected to adopt its mandate during the plenary session on February 7, 2024, after which it will be ready to commence negotiations with EU Member States.
  • It is crucial not to miss the opportunity to progress in the approval of this regulation, as it will contribute to establishing more appropriate and aligned regulations regarding plants and products resulting from NGTs.
  • The European Union has the opportunity to promote a safer, more sustainable, and more resilient agri-food system, but it is necessary to establish an adequate, predictable regulatory framework that enhances innovations derived from these techniques.
Laboratorio_biotecnología_AseBio
AseBio
Biotechnology is revolutionizing the present and future of the fight against cancer
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
  • Immunotherapy, gene therapy, the study of mRNA and its potential application in vaccines, nanotechnology, liquid biopsy, the development of specific biomarkers, and CAR-T cells are just a few examples of biotechnological advances against cancer.
  • Sixty-three percent of AseBio's pipeline research (350 research lines from national and multinational companies with subsidiaries in Spain) is focused on finding a treatment for cancer.
  • Furthermore, 28% of disease diagnostic products developed by our partner companies are targeted towards cancer.